These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32843972)

  • 21. Carcinogenesis of Barrett's esophagus: a review of the clinical literature.
    Watari J; Oshima T; Fukui H; Tomita T; Miwa H
    Clin J Gastroenterol; 2013 Dec; 6(6):399-414. PubMed ID: 26182128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effect of Proton Pump Inhibitors on Barrett's Esophagus.
    Dunbar KB; Souza RF; Spechler SJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):415-24. PubMed ID: 26021202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.
    Samuels T; Hoekzema C; Gould J; Goldblatt M; Frelich M; Bosler M; Lee SH; Johnston N
    Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):893-902. PubMed ID: 26077392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of esophageal adenocarcinoma formation and approaches to chemopreventive intervention.
    Richmond E; Umar A
    Semin Oncol; 2016 Feb; 43(1):78-85. PubMed ID: 26970126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preference of endoscopic ablation over medical prevention of esophageal adenocarcinoma by patients with Barrett's esophagus.
    Yachimski P; Wani S; Givens T; Howard E; Higginbotham T; Price A; Berman K; Hosford L; Katcher PM; Ozanne E; Perzan K; Hur C
    Clin Gastroenterol Hepatol; 2015 Jan; 13(1):84-90. PubMed ID: 24681073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low Risk of Progression of Barrett's Esophagus to Neoplasia in Women.
    Allen JE; Desai M; Roumans CAM; Vennalaganti S; Vennalaganti P; Bansal A; Falk G; Lieberman D; Sampliner R; Thota P; Vargo J; Gupta N; Moawad F; Bruno M; Kennedy KF; Gaddam S; Young P; Mathur S; Cash B; Spaander M; Sharma P
    J Clin Gastroenterol; 2021 Apr; 55(4):321-326. PubMed ID: 32379085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial.
    Jankowski JAZ; de Caestecker J; Love SB; Reilly G; Watson P; Sanders S; Ang Y; Morris D; Bhandari P; Brooks C; Attwood S; Harrison R; Barr H; Moayyedi P;
    Lancet; 2018 Aug; 392(10145):400-408. PubMed ID: 30057104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
    Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
    Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
    Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
    Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statins and aspirin for chemoprevention in Barrett's esophagus: results of a cost-effectiveness analysis.
    Choi SE; Perzan KE; Tramontano AC; Kong CY; Hur C
    Cancer Prev Res (Phila); 2014 Mar; 7(3):341-50. PubMed ID: 24380852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus.
    Hur C; Broughton DE; Ozanne E; Yachimski P; Nishioka NS; Gazelle GS
    Am J Gastroenterol; 2008 Oct; 103(10):2432-42. PubMed ID: 18775019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent developments in esophageal adenocarcinoma.
    Lagergren J; Lagergren P
    CA Cancer J Clin; 2013; 63(4):232-48. PubMed ID: 23818335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin use is associated with a reduction in the incidence of esophageal adenocarcinoma: a case control study.
    Beales IL; Vardi I; Dearman L; Broughton T
    Dis Esophagus; 2013; 26(8):838-46. PubMed ID: 22989236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemoprevention.
    Kresty LA; Clarke J; Ezell K; Exum A; Howell AB; Guettouche T
    J Carcinog; 2011; 10():34. PubMed ID: 22279419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
    Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
    Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current state of prognostication, therapy and prospective innovations for Barrett's-related esophageal adenocarcinoma: a literature review.
    Mittal SK; Abdo J; Adrien MP; Bayu BA; Kline JR; Sullivan MM; Agrawal DK
    J Gastrointest Oncol; 2021 Aug; 12(4):1197-1214. PubMed ID: 34532080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonsteroidal anti-inflammatory drugs and esophageal inflammation - Barrett's esophagus - adenocarcinoma sequence: a meta-analysis.
    Wang F; Lv ZS; Fu YK
    Dis Esophagus; 2011 Jul; 24(5):318-24. PubMed ID: 21166737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Esophageal Adenocarcinoma and Its Rare Association with Barrett's Esophagus in Henan, China.
    Liu S; Dai JY; Yao L; Li X; Reid B; Self S; Ma J; Chang Y; Feng S; Tapsoba Jde D; Sun X; Sun X
    PLoS One; 2014; 9(10):e110348. PubMed ID: 25333822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of incremental effect of histamine receptor antagonists over proton pump inhibitors on the risk of neoplastic progression in patients with Barrett's esophagus: a cohort study.
    Thota PN; Hajifathalian K; Benjamin T; Runkana A; Lopez R; Sanaka MR
    J Dig Dis; 2017 Mar; 18(3):143-150. PubMed ID: 28188977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus.
    Critchley-Thorne RJ; Davison JM; Prichard JW; Reese LM; Zhang Y; Repa K; Li J; Diehl DL; Jhala NC; Ginsberg GG; DeMarshall M; Foxwell T; Jobe BA; Zaidi AH; Duits LC; Bergman JJ; Rustgi A; Falk GW
    Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):240-248. PubMed ID: 27729357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.